Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor

Goro Hiroishi, Toshinori Murata, Tatsuro Ishibashi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: To investigate the effect of troglitazone, an antidiabetic drug, on the cytosolic Ca2+ concentrations ([Ca2+]i) and the cell cycles of bovine retinal endothelial cells (RECs) stimulated with vascular endothelial growth factor (VEGF). Methods: The changes in [Ca2+]i were monitored using microfluorometry with Fura-2. The phase of the cell cycle was examined by an immunocytochemical analysis using monoclonal antibodies against cell cycle-specific nuclear antigens. Results: In the presence of extracellular Ca2+, VEGF-induced transient [Ca2+]i elevation followed by continuous steady-state elevation resulted in cell cycle progression in RECs. The removal of extracellular Ca2+ inhibited the continuous component, but transient [Ca2+]i elevation was still observed. These results are compatible with the hypothesis that a continuous steady-state elevation of [Ca2+]i may be mediated mainly through the influx of extracellular Ca2+. Pretreatment with 10 μM troglitazone prevented the transient and continuous steady-state elevation of [Ca 2+]i, resulting in an inhibition of the cell cycle in RECs stimulated with VEGF. Conclusions: These data suggest that troglitazone inhibits VEGF-induced cell cycle progression through the inhibition of [Ca2+]i in RECs.

Original languageEnglish
Pages (from-to)21-26
Number of pages6
JournalJapanese Journal of Ophthalmology
Volume51
Issue number1
DOIs
Publication statusPublished - Jan 1 2007

Fingerprint

troglitazone
Vascular Endothelial Growth Factor A
Cell Cycle
Endothelial Cells
Cytophotometry
Nuclear Antigens
Fura-2
Hypoglycemic Agents
2,4-thiazolidinedione
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor. / Hiroishi, Goro; Murata, Toshinori; Ishibashi, Tatsuro.

In: Japanese Journal of Ophthalmology, Vol. 51, No. 1, 01.01.2007, p. 21-26.

Research output: Contribution to journalArticle

@article{1d8465fa55fe417290cd446a58243983,
title = "Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor",
abstract = "Purpose: To investigate the effect of troglitazone, an antidiabetic drug, on the cytosolic Ca2+ concentrations ([Ca2+]i) and the cell cycles of bovine retinal endothelial cells (RECs) stimulated with vascular endothelial growth factor (VEGF). Methods: The changes in [Ca2+]i were monitored using microfluorometry with Fura-2. The phase of the cell cycle was examined by an immunocytochemical analysis using monoclonal antibodies against cell cycle-specific nuclear antigens. Results: In the presence of extracellular Ca2+, VEGF-induced transient [Ca2+]i elevation followed by continuous steady-state elevation resulted in cell cycle progression in RECs. The removal of extracellular Ca2+ inhibited the continuous component, but transient [Ca2+]i elevation was still observed. These results are compatible with the hypothesis that a continuous steady-state elevation of [Ca2+]i may be mediated mainly through the influx of extracellular Ca2+. Pretreatment with 10 μM troglitazone prevented the transient and continuous steady-state elevation of [Ca 2+]i, resulting in an inhibition of the cell cycle in RECs stimulated with VEGF. Conclusions: These data suggest that troglitazone inhibits VEGF-induced cell cycle progression through the inhibition of [Ca2+]i in RECs.",
author = "Goro Hiroishi and Toshinori Murata and Tatsuro Ishibashi",
year = "2007",
month = "1",
day = "1",
doi = "10.1007/s10384-006-0385-2",
language = "English",
volume = "51",
pages = "21--26",
journal = "Japanese Journal of Ophthalmology",
issn = "0021-5155",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Effect of thiazolidinedione on the proliferation of bovine retinal endothelial cells stimulated by vascular endothelial cell growth factor

AU - Hiroishi, Goro

AU - Murata, Toshinori

AU - Ishibashi, Tatsuro

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Purpose: To investigate the effect of troglitazone, an antidiabetic drug, on the cytosolic Ca2+ concentrations ([Ca2+]i) and the cell cycles of bovine retinal endothelial cells (RECs) stimulated with vascular endothelial growth factor (VEGF). Methods: The changes in [Ca2+]i were monitored using microfluorometry with Fura-2. The phase of the cell cycle was examined by an immunocytochemical analysis using monoclonal antibodies against cell cycle-specific nuclear antigens. Results: In the presence of extracellular Ca2+, VEGF-induced transient [Ca2+]i elevation followed by continuous steady-state elevation resulted in cell cycle progression in RECs. The removal of extracellular Ca2+ inhibited the continuous component, but transient [Ca2+]i elevation was still observed. These results are compatible with the hypothesis that a continuous steady-state elevation of [Ca2+]i may be mediated mainly through the influx of extracellular Ca2+. Pretreatment with 10 μM troglitazone prevented the transient and continuous steady-state elevation of [Ca 2+]i, resulting in an inhibition of the cell cycle in RECs stimulated with VEGF. Conclusions: These data suggest that troglitazone inhibits VEGF-induced cell cycle progression through the inhibition of [Ca2+]i in RECs.

AB - Purpose: To investigate the effect of troglitazone, an antidiabetic drug, on the cytosolic Ca2+ concentrations ([Ca2+]i) and the cell cycles of bovine retinal endothelial cells (RECs) stimulated with vascular endothelial growth factor (VEGF). Methods: The changes in [Ca2+]i were monitored using microfluorometry with Fura-2. The phase of the cell cycle was examined by an immunocytochemical analysis using monoclonal antibodies against cell cycle-specific nuclear antigens. Results: In the presence of extracellular Ca2+, VEGF-induced transient [Ca2+]i elevation followed by continuous steady-state elevation resulted in cell cycle progression in RECs. The removal of extracellular Ca2+ inhibited the continuous component, but transient [Ca2+]i elevation was still observed. These results are compatible with the hypothesis that a continuous steady-state elevation of [Ca2+]i may be mediated mainly through the influx of extracellular Ca2+. Pretreatment with 10 μM troglitazone prevented the transient and continuous steady-state elevation of [Ca 2+]i, resulting in an inhibition of the cell cycle in RECs stimulated with VEGF. Conclusions: These data suggest that troglitazone inhibits VEGF-induced cell cycle progression through the inhibition of [Ca2+]i in RECs.

UR - http://www.scopus.com/inward/record.url?scp=33847139760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847139760&partnerID=8YFLogxK

U2 - 10.1007/s10384-006-0385-2

DO - 10.1007/s10384-006-0385-2

M3 - Article

C2 - 17295136

AN - SCOPUS:33847139760

VL - 51

SP - 21

EP - 26

JO - Japanese Journal of Ophthalmology

JF - Japanese Journal of Ophthalmology

SN - 0021-5155

IS - 1

ER -